Formation Bio is a tech-driven, AI-native pharmaceutical company focused on accelerating drug development by acquiring clinical-stage assets and advancing them more efficiently through proprietary technology. The company aims to bring new treatments to patients faster across therapeutic areas by improving the drug development lifecycle while maintaining quality and safety. Their multidisciplinary team combines expertise in drug selection, drug development, and technology to shorten development timelines and create greater value per program.
No recent deals for this company.